People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Athersys, Inc / New | — | Biotechnology | Series A | $12.5M | $33.2M | 2023 |
JANE WASMAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JANE WASMAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph Nolan | 1 | 5 |
| Lorin J Randall | 1 | 3 |
| ISMAIL KOLA | 1 | 2 |
| Laura K. Campbell | 1 | 1 |
| William L. Lehmann | 1 | 1 |
| Gil Van Bokkelen | 1 | 1 |
| Ismail E. Kola | 1 | 1 |
| Jack L. Wyszomlerski | 1 | 1 |
| George M. Milne | 1 | 1 |
| DANIEL CAMARDO | 1 | 1 |
| JACK WYSZOMIERSKI | 1 | 1 |
| KASEY ROSADO | 1 | 1 |
| MAIA HANSEN | 1 | 1 |
| John J. Harrington | 1 | 1 |
| Lee E. Babiss | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.